scholarly journals PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY

2011 ◽  
Vol 14 (3) ◽  
pp. A192-A193
Author(s):  
H. Svedsater ◽  
J. Locklear ◽  
S. Johal ◽  
I.O. Stillman
Keyword(s):  
Major Depressive Disorder ◽  
Cost Effectiveness ◽  
Depressive Disorder ◽  
Extended Release ◽  
Budget Impact ◽  
Inadequate Response ◽  
Major Depressive ◽  
Quetiapine Fumarate ◽  
Previous Therapy

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

2009 ◽  
Vol 70 (4) ◽  
pp. 526-539 ◽  
Author(s):  
Andrew J. Cutler ◽  
Stuart A. Montgomery ◽  
David Feifel ◽  
Arthur Lazarus ◽  
Mikael Åström ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Extended Release ◽  
Major Depressive ◽  
Quetiapine Fumarate

Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder

2014 ◽  
Vol 29 (2) ◽  
pp. 93-105 ◽  
Author(s):  
Stuart A. Montgomery ◽  
A. Carlo Altamura ◽  
Heikki Katila ◽  
Catherine Datto ◽  
Johan Szamosi ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Elderly Patients ◽  
Extended Release ◽  
Major Depressive ◽  
Quetiapine Fumarate
Sign in / Sign up

Export Citation Format

Share Document